201 related articles for article (PubMed ID: 34076871)
41. LncRNA HOXA-AS2 positively regulates osteogenesis of mesenchymal stem cells through inactivating NF-κB signalling.
Zhu X; Yu J; Du J; Zhong G; Qiao L; Lin J
J Cell Mol Med; 2019 Feb; 23(2):1325-1332. PubMed ID: 30536618
[TBL] [Abstract][Full Text] [Related]
42. Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop.
Zhang X; Niu W; Mu M; Hu S; Niu C
J Exp Clin Cancer Res; 2020 Sep; 39(1):196. PubMed ID: 32962742
[TBL] [Abstract][Full Text] [Related]
43. LncRNA BBOX1-AS1 upregulates HOXC6 expression through miR-361-3p and HuR to drive cervical cancer progression.
Xu J; Yang B; Wang L; Zhu Y; Zhu X; Xia Z; Zhao Z; Xu L
Cell Prolif; 2020 Jul; 53(7):e12823. PubMed ID: 32515533
[TBL] [Abstract][Full Text] [Related]
44. USF1-induced overexpression of long noncoding RNA WDFY3-AS2 promotes lung adenocarcinoma progression via targeting miR-491-5p/ZNF703 axis.
Ren P; Hong X; Chang L; Xing L; Zhang H
Mol Carcinog; 2020 Aug; 59(8):875-885. PubMed ID: 32275336
[TBL] [Abstract][Full Text] [Related]
45. Long non-coding RNA WT1-AS inhibits cell aggressiveness via miR-203a-5p/FOXN2 axis and is associated with prognosis in cervical cancer.
Dai SG; Guo LL; Xia X; Pan Y
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):486-495. PubMed ID: 30720155
[TBL] [Abstract][Full Text] [Related]
46. Overexpression of HOXA-AS2 LncRNA in Patients with Gastric Cancer and Its Association with Helicobacter pylori Infection.
Rajabi A; Riahi A; Shirabadi-Arani H; Moaddab Y; Haghi M; Safaralizadeh R
J Gastrointest Cancer; 2022 Mar; 53(1):72-77. PubMed ID: 33174119
[TBL] [Abstract][Full Text] [Related]
47. The Long Non-Coding RNA
Le Boiteux E; Guichet PO; Masliantsev K; Montibus B; Vaurs-Barriere C; Gonthier-Gueret C; Chautard E; Verrelle P; Karayan-Tapon L; Fogli A; Court F; Arnaud P
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563134
[TBL] [Abstract][Full Text] [Related]
48. LncRNA DLEU2 promotes cervical cancer cell proliferation by regulating cell cycle and NOTCH pathway.
He M; Wang Y; Cai J; Xie Y; Tao C; Jiang Y; Li H; Song F
Exp Cell Res; 2021 May; 402(1):112551. PubMed ID: 33675808
[TBL] [Abstract][Full Text] [Related]
49. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer.
Chen M; Zhuang C; Liu Y; Li J; Dai F; Xia M; Zhan Y; Lin J; Chen Z; He A; Xu W; Zhao G; Guo Y; Cai Z; Huang W
Cancer Lett; 2016 Jun; 376(1):155-64. PubMed ID: 27018306
[TBL] [Abstract][Full Text] [Related]
50. Integrated RNA Sequencing and Single-Cell Mass Cytometry Reveal a Novel Role of LncRNA HOXA-AS2 in Tumorigenesis and Stemness of Hepatocellular Carcinoma.
Lu Q; Gao J; Tang S; Li Z; Wang X; Deng C; Hu J; Tao Y; Wang Q
Onco Targets Ther; 2020; 13():10901-10916. PubMed ID: 33149607
[TBL] [Abstract][Full Text] [Related]
51. Long non-coding RNA, steroid receptor RNA activator (SRA), induces tumor proliferation and invasion through the NOTCH pathway in cervical cancer cell lines.
Eoh KJ; Paek J; Kim SW; Kim HJ; Lee HY; Lee SK; Kim YT
Oncol Rep; 2017 Dec; 38(6):3481-3488. PubMed ID: 29039612
[TBL] [Abstract][Full Text] [Related]
52. HOXD-AS1 facilitates cell migration and invasion as an oncogenic lncRNA by competitively binding to miR-877-3p and upregulating FGF2 in human cervical cancer.
Chen S; Li K
BMC Cancer; 2020 Sep; 20(1):924. PubMed ID: 32977766
[TBL] [Abstract][Full Text] [Related]
53. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1.
Wang YG; Wang T; Shi M; Zhai B
J Exp Clin Cancer Res; 2019 Apr; 38(1):153. PubMed ID: 30971290
[TBL] [Abstract][Full Text] [Related]
54. LncRNA HOXA-AS2 promotes glioblastoma carcinogenesis by targeting miR-885-5p/RBBP4 axis.
Shou J; Gao H; Cheng S; Wang B; Guan H
Cancer Cell Int; 2021 Jan; 21(1):39. PubMed ID: 33430870
[TBL] [Abstract][Full Text] [Related]
55. Long noncoding RNA HOXA-AS2 mediates microRNA-106b-5p to repress sepsis-engendered acute kidney injury.
Wu H; Wang J; Ma Z
J Biochem Mol Toxicol; 2020 Apr; 34(4):e22453. PubMed ID: 32048402
[TBL] [Abstract][Full Text] [Related]
56. HOX antisense lincRNA HOXA-AS2 is an apoptosis repressor in all trans retinoic acid treated NB4 promyelocytic leukemia cells.
Zhao H; Zhang X; Frazão JB; Condino-Neto A; Newburger PE
J Cell Biochem; 2013 Oct; 114(10):2375-83. PubMed ID: 23649634
[TBL] [Abstract][Full Text] [Related]
57. Correlation between long strand non-coding RNA GASS expression and prognosis of cervical cancer patients.
Li Y; Wan YP; Bai Y
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):943-949. PubMed ID: 29509242
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of lncRNA DCST1-AS1 suppresses proliferation, migration and invasion of cervical cancer cells by increasing miR-874-3p expression.
Liu J; Zhang J; Hu Y; Zou H; Zhang X; Hu X
J Gene Med; 2021 Jan; 23(1):e3281. PubMed ID: 33025624
[TBL] [Abstract][Full Text] [Related]
59. [Silencing long non-coding RNA HIF1A-AS2 inhibits proliferation, invasion and migration of cervical cancer cells
Deng R; Zhang F; Lei F; Liu W; Liu S; Wang W
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Nov; 40(11):1615-1621. PubMed ID: 33243752
[TBL] [Abstract][Full Text] [Related]
60. LncRNA HOXA‑AS2 is a prognostic and clinicopathological predictor in patients with cancer: A meta‑analysis.
Xiao T; Yan A; Tan L; Zhu H; Gao W
Oncol Lett; 2024 May; 27(5):226. PubMed ID: 38586205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
